Media Inquiries

If you are a credentialed member of the media, please submit a request via this link: Request For Comment | HHS.gov. If you are a scientist who has been contacted by a member of the media, please refer them to the link above.

News and Events

Immunofluorescence image of the cell adhesion protein basigin (turquoise) in TuNEPs released from dying 4T1 mouse breast cancer cells.

Proteins Released from the Nuclei of Dying Cancer Cells Promote Tumor Growth

Material released from dying cancer cells, known as tumor cell nuclear expulsion products (TuNEPs), contains specific proteins that promote the growth of neighboring cancer cells. Targeting these proteins could lead to new treatments that hinder cancer spread and improve patient outcomes.

Celebrating AANHPI Heritage Month: A Conversation with Suresh Ambudkar, Ph.D.

Suresh V. Ambudkar, Ph.D., is a Senior Investigator and the Deputy Chief of the Laboratory of Cell Biology. For this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, he answers some questions about his academic, research and personal journey immigrating from India to the United States.

Clinical trial researching immunotherapy for B-cell lymphoma

A clinical trial led by Mark Roschewski, M.D., Senior Clinician in the Lymphoid Malignancies Branch, is researching immunotherapy for indolent B-cell lymphoma, a cancer of white blood cells that frequently relapses.

Machine learning reveals rules of T cell activation

CCR and McGill University scientists have used machine learning to build models that can predict T cell responses against tumors.

Kreitman trial CAR T cell therapy description

Clinical trial researches CAR T-cell therapy for hairy cell leukemia

Robert J. Kreitman, M.D., Senior Investigator in the Laboratory of Molecular Biology, is leading a study to see whether CAR T-cell therapy impacts patients with hairy cell leukemia.

Clinical trials research immunotherapy for Kaposi sarcoma

Clinical trials led by Ramya Ramaswami, M.B.B.S., M.P.H., Physician-Scientist Early Investigator in the HIV and AIDS Malignancy Branch, are researching immunotherapy for Kaposi sarcoma.

In Memoriam: Joost J. Oppenheim, M.D. (1934–2022)

The CCR mourns the recent passing of colleague and friend Joost Oppenheim, M.D., Senior Investigator and Head of the Cellular Immunology Section in the Cancer Innovation Laboratory.

Michael Lichten, Ph.D.; Deborah K. Morrison, Ph.D.; Mary N. Carrington, Ph.D.; Susan M. Lea, D.Phil., F.Med.Sci.

Four CCR researchers receive high honors

CCR Senior Investigators Michael Lichten, Ph.D., Deborah Morrison, Ph.D., Mary Carrington, Ph.D, and Susan Lea, D.Phil., F.Med.Sci., have been elected to notable scientific academies and societies in recognition of their significant and impactful research accomplishments.

Elaine S. Jaffe receives HHS Career Achievement Award

Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, was awarded a 2022 Career Achievement Award by the Department of Health and Human Services in recognition of her groundbreaking advances in the diagnosis and treatment of patients with blood cancers.

Male patient discusses pain with female doctor

Clinical trial researching PSMA imaging in prostate cancer

A clinical trial led by Deborah E. Citrin, M.D., Senior Investigator in the Radiation Oncology Branch, is researching prostate-specific membrane antigen (PSMA) imaging to evaluate response to radiation treatment in patients with prostate cancer.

a group of killer T cells (light blue) surround a cancer cell (dark red/black)

Computational model finds signatures of T cell resilience in solid tumors

Evaluating T cell resilience can help researchers predict — and possibly improve — immunotherapy outcomes.

Breadcrumb

News and Events